These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6377497)

  • 1. A model study of fecapentaenes: mutagens of bacterial origin with alkylating properties.
    Gupta I; Suzuki K; Bruce RW; Krepinsky JJ; Yates P
    Science; 1984 Aug; 225(4661):521-3. PubMed ID: 6377497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecapentaene concentration and mutagenicity in 718 North American stool samples.
    Schiffman MH; Van Tassell RL; Andrews AW; Wacholder S; Daniel J; Robinson A; Smith L; Nair PP; Wilkins TD
    Mutat Res; 1989 Apr; 222(4):351-7. PubMed ID: 2649794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenic activities of fecapentaene derivatives in the Ames/Salmonella test system.
    Peters JH; Riccio ES; Stewart KR; Reist EJ
    Cancer Lett; 1988 Apr; 39(3):287-96. PubMed ID: 3282644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of the genotoxicity of fecapentaenes.
    Nair PP; Shami S; Sainz E; Judd JT; Taylor PR; Schatzkin A
    Mutat Res; 1991 Jun; 260(2):153-7. PubMed ID: 1904547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory and epidemiologic studies of fecapentaenes.
    Povey AC; Schiffman M; Taffe BG; Harris CC
    Mutat Res; 1991; 259(3-4):387-97. PubMed ID: 2017218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bacterial mutagenicity of synthetic all-trans fecapentaene-12 changes when assayed under anaerobic conditions.
    Venitt S; Bosworth D
    Mutagenesis; 1988 Mar; 3(2):169-73. PubMed ID: 3288841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electron spin resonance spectroscopy of oxygen radicals generated by synthetic fecapentaene-12 and reduction of fecapentaene mutagenicity to Salmonella typhimurium by hydroxyl radical scavenging.
    de Kok TM; van Maanen JM; Lankelma J; ten Hoor F; Kleinjans JC
    Carcinogenesis; 1992 Jul; 13(7):1249-55. PubMed ID: 1322251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and quantitative distribution of eight analogues of naturally occurring fecapentaenes in human feces by high-performance liquid chromatography.
    de Kok TM; ten Hoor F; Kleinjans JC
    Carcinogenesis; 1991 Feb; 12(2):199-205. PubMed ID: 1995185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, chemical reactivity, and in vitro mutagenic activity in a series of fecapentaene analogues.
    Voogd CE; Vertegaal LB; van der Steeg M; van der Gen A; Mohn GR
    Mutat Res; 1990 Mar; 243(3):195-9. PubMed ID: 2407953
    [No Abstract]   [Full Text] [Related]  

  • 10. Further studies on the mutagenic activity of fecapentaene-12 analogues and conclusions about their molecular mode of action.
    Vertegaal LB; Voogd CE; Mohn GR; van der Gen A
    Mutat Res; 1992 Feb; 281(2):93-8. PubMed ID: 1370987
    [No Abstract]   [Full Text] [Related]  

  • 11. Structure-activity relationships in the mutagenicity of N-substituted derivatives of phenanthrene-9,10-imine.
    Stark AA; Zeiger E; Shtelzer S; Sheradsky T; Lifshitz Y; Blum J
    Mutagenesis; 1986 Jan; 1(1):35-9. PubMed ID: 3325734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noncovalent DNA binding and the mechanism of oxidative DNA damage by fecapentaene-12.
    Szekely J; Gates KS
    Chem Res Toxicol; 2006 Jan; 19(1):117-21. PubMed ID: 16411664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of colorectal cancer and fecal mutagenicity.
    Schiffman MH; Andrews AW; Van Tassell RL; Smith L; Daniel J; Robinson A; Hoover RN; Rosenthal J; Weil R; Nair PP
    Cancer Res; 1989 Jun; 49(12):3420-4. PubMed ID: 2655896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenic properties of N-cyclopropyl and N-allyl-N-nitroso compounds. Studies on the nature of alkylating species.
    Wiessler M; Pool BL
    Carcinogenesis; 1984 May; 5(5):635-9. PubMed ID: 6373041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecapentaene-12 causes DNA damage and mutations in human cells.
    Plummer SM; Grafstrom RC; Yang LL; Curren RD; Linnainmaa K; Harris CC
    Carcinogenesis; 1986 Sep; 7(9):1607-9. PubMed ID: 3742732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of mutagenic properties in a series of DNA-directed alkylating agents by variation of chain length and alkylator reactivity.
    Ferguson LR; Turner PM; Pogai H; Denny WA
    Mutat Res; 1992 Feb; 265(2):181-93. PubMed ID: 1370717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity of synthetic racemic fecapentaene-12.
    Göggelmann W; Maier FK; Pfaendler HR
    Mutat Res; 1986 Jul; 174(3):165-7. PubMed ID: 3523232
    [No Abstract]   [Full Text] [Related]  

  • 18. Fecapentaene excretion and fecal mutagenicity in relation to nutrient intake and fecal parameters in humans on omnivorous and vegetarian diets.
    de Kok TM; van Faassen A; Bausch-Goldbohm RA; ten Hoor F; Kleinjans JC
    Cancer Lett; 1992 Feb; 62(1):11-21. PubMed ID: 1540928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of steric effects in the direct mutagenicity of N-acyloxy-N-alkoxyamides.
    Andrews LE; Bonin AM; Fransson LE; Gillson AM; Glover SA
    Mutat Res; 2006 Jun; 605(1-2):51-62. PubMed ID: 16698311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxic mechanisms of fecapentaene-12 in human cells.
    Povey AC; Plummer SM; Grafstrom RC; Harris CC
    Prog Clin Biol Res; 1990; 347():155-66. PubMed ID: 2217387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.